226 related articles for article (PubMed ID: 19546587)
1. The Impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders.
Karamé A; Labeeuw M; Trolliet P; Caillette-Beaudoin A; Cahen R; Ecochard R; Galland R; Hallonet P; Pouteil-Noble C; Villar E
Nephron Clin Pract; 2009; 112(4):c268-75. PubMed ID: 19546587
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
3. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.
Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H
Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858
[TBL] [Abstract][Full Text] [Related]
4. Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival.
Bechtel JF; Detter C; Fischlein T; Krabatsch T; Osswald BR; Riess FC; Scholz F; Schönburg M; Stamm C; Sievers HH; Bartels C
Ann Thorac Surg; 2008 Jan; 85(1):147-53. PubMed ID: 18154800
[TBL] [Abstract][Full Text] [Related]
5. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
[TBL] [Abstract][Full Text] [Related]
6. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
Villar E; Chang SH; McDonald SP
Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
[TBL] [Abstract][Full Text] [Related]
7. Late referral defined by renal function: association with morbidity and mortality.
Lhotta K; Zoebl M; Mayer G; Kronenberg F
J Nephrol; 2003; 16(6):855-61. PubMed ID: 14736013
[TBL] [Abstract][Full Text] [Related]
8. Current and former smoking increases mortality in patients on peritoneal dialysis.
Braatvedt GD; Rosie B; Bagg W; Collins J
N Z Med J; 2006 May; 119(1234):U1977. PubMed ID: 16718288
[TBL] [Abstract][Full Text] [Related]
9. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
10. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study.
Lee CK; Christensen LL; Magee JC; Ojo AO; Harmon WE; Bridges ND
J Heart Lung Transplant; 2007 May; 26(5):458-65. PubMed ID: 17449414
[TBL] [Abstract][Full Text] [Related]
12. Survival on chronic dialysis: 10 years' experience of a single Colombian center.
Enríquez J; Bastidas M; Mosquera M; Ceballos O; Bastidas B; Argote E; Salazar J; Delgado M
Adv Perit Dial; 2005; 21():164-7. PubMed ID: 16686311
[TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of heart transplant patients with end-stage renal failure.
Villar E; Boissonnat P; Sebbag L; Hendawy A; Cahen R; Trolliet P; Labeeuw M; Ecochard R; Pouteil-Noble C
Nephrol Dial Transplant; 2007 May; 22(5):1383-9. PubMed ID: 17267535
[TBL] [Abstract][Full Text] [Related]
14. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
[TBL] [Abstract][Full Text] [Related]
15. [Survival analysis of diabetic patients on dialysis in Guadeloupe].
Foucan L; Mérault H; Deloumeaux J; Ekouévi DK; Kangambéga P; Messerchmitt C; Gabriel JM
Diabetes Metab; 2000 Sep; 26(4):307-13. PubMed ID: 11011224
[TBL] [Abstract][Full Text] [Related]
16. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.
Liao CT; Chen YM; Shiao CC; Hu FC; Huang JW; Kao TW; Chuang HF; Hung KY; Wu KD; Tsai TJ
Nephrol Dial Transplant; 2009 Sep; 24(9):2909-14. PubMed ID: 19225016
[TBL] [Abstract][Full Text] [Related]
17. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
[TBL] [Abstract][Full Text] [Related]
18. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
Götz AK; Böger CA; Popal M; Banas B; Krämer BK
Nephron Clin Pract; 2008; 109(3):c154-60. PubMed ID: 18663328
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
20. Impact of cadaveric renal transplantation on survival in patients listed for transplantation.
Oniscu GC; Brown H; Forsythe JL
J Am Soc Nephrol; 2005 Jun; 16(6):1859-65. PubMed ID: 15857921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
